GSN and amyloidosis: Due to the simple pathophysiology and accessibility of the amyloidogenic peptides, gelsolin amyloidosis could serve as an optimal model disease to test the still not fully validated amyloid hypothesis prevailing in the field of neurodegenerative diseases.